Register entry
- Registered sites
- 0
- Active NDC listings
- 16
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1616 active NDC listings: 16 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 15, EXPORT ONLY 1.
| Dosage form | NDCs |
|---|---|
| tablet | 8 |
| tablet, film coated | 4 |
| powder | 3 |
| tablet, extended release | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| patheon puerto rico, inc. | 16 |
Catalogue
Marketed products
16| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Metformin Hydrochloride | powder | 55370-824DRUG FOR FURTHER PROCESSING |
| - | Metformin Hydrochloride | powder | 55370-826DRUG FOR FURTHER PROCESSING |
| - | Metformin Hydrochloride | powder | 55370-827DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | tablet, film coated | 55370-001DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | tablet, film coated | 55370-002DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | tablet, film coated | 55370-003DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | tablet, film coated | 55370-006EXPORT ONLY |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-794DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-795DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-796DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-797DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-799DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-800DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-823DRUG FOR FURTHER PROCESSING |
| - | empagliflozin and metformin hydrochloride | tablet | 55370-825DRUG FOR FURTHER PROCESSING |
| - | loratadine and pseudoephedrine sulfate | tablet, extended release | 55370-790DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing empagliflozin and metformin hydrochloride
- Boehringer Ingelheim Biopharmaceuticals China Ltd3 sites · 127 NDC
Enquiry
Common questions
- Is Patheon Puerto Rico, Inc. FDA approved?
- Patheon Puerto Rico, Inc. holds no registered establishment of its own; 16 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Patheon Puerto Rico, Inc. make?
- 16 products are listed under Patheon Puerto Rico, Inc. in the openFDA NDC Directory, most often as tablet; tablet, film coated; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.